Toxicological Research

Korean Society of Toxicology & Korea Environmental Mutagen Society (한국독성학회)
권호 표지

2,4-Dinitrochlorobenzene-induced Atopic Dermatitis Like Immune Alteration in Mice

마우스에서 2,4-Dinitrochlorobenzene을 이용한 아토피성 피부염 발현 관련 면역지표치 분석

  • Lee, Seung-Hye (Catholic University of Daegu, College of Natural Sciences, Dept. Occupational Health) ;
  • Baek, Seong-Jin (Biotoxtech Co., Ltd) ;
  • Kim, Hyoung-Ah (The Catholic University of Korea, College of Medicine, Dept. Preventive Medicine) ;
  • Heo, Yong (Catholic University of Daegu, College of Natural Sciences, Dept. Occupational Health)
  • 이승혜 (대구가톨릭대학교 자연대학 산업보건학과) ;
  • 백성진 (주식회사 바이오톡스텍) ;
  • 김형아 (가톨릭대학교 의과대학 예방의학교실) ;
  • 허용 (대구가톨릭대학교 자연대학 산업보건학과)
  • Published : 2006.12.30
Download PDF
⟨ Previous Next ⟩

Abstract

This study was undertaken to develop a reliable mice model demonstrating similar immunologic phenomena as human atopic dermatitis characterized with predominance of type-2 immune response. BALB/C mice and NC/Nga mice were sensitized twice with $100{\mu}l$ of 1% 2,4-dinitrochlorobenzene (DNCB) or vehicle (acetone : olive oil=4:1 mixture) in a week and challenged twice with $100{\mu}l$ of 0.2% DNCB or the vehicle at the following week. Mice were sacrificed at 19 days following the second DNCB or vehicle challenge for NC/Nga mice and at 28 days following the second DNCB or vehicle challenge for BALB/c mice. Upregulation of plasma 1gE, a hallmark of atopic dermatitis occurrence, was evident in the plasma obtained 4 day after the second DNCB challenge from BALB/c mice (approximately 4-fold) and NC/Nga mice (approximately 6-fold) treated with DNCB in comparison with that of the vehicle treated-control mice, and remain higher $3{\sim}4$ week after the second challenge. Ratio of plasma IgG1 versus IgG2a concentration was significantly higher in the mice treated with DNCB than the control mice, which also implies the skewed type-2 reactivity in vivo. Ratio of interleukin-4 versus interferon gamma produced in the splenic T cell culture supernatants was approximately 3-fold higher in the both strains of mice treated with DNCB than their control mice, respectively. The DNCB-treated mice demonstrated atopic dermatitis-like skin legions characterized with erythma, scaling, and hemorrhage, which was not observed with the control mice. Scratching on face or dorsal area was significantly more frequent (approximately 25-fold) in the DNCB-treated mice than the control at next day of the second DNCB challenge, and scratching frequency remains higher (approximately 4-fold) in the mice treated with DNCB than the control at 14 day following the second DNCB challenge. Overall, the mice model developed through sensitization and challenge with DNCB may be useful for research on atopic dermatitis and development of treatment materials for atopic dermatitis.

Keywords

References

  1. Abdel-Hamid, K.M. (2003): Atopic dermatitis in Allergy, Asthma, and Immunology Subspecialty Consult (B.C. Jost, E. Friedman, K.M. Abdel-Hamid, A.L. Jani, Ed.). Lippincott Williams & Wilins, Philadelphia, pp. 66-73
  2. Boguniewicz, M. and Beltrani, V.S. (2002): Atopic dermatitis and contact dermatitis in Manual of Allergy and Immunology (D.C. Adelman, T.B. Casale, J. Corren, Ed.). Lippincott Williams & Wilins, Philadelphia, pp. 165-186
  3. Caron, G., Delneste, Y., Roelandts, E., Duez, C., Bonnefoy, J.Y., Pestel, J. and Jeannin, P. (2001): Histamine polarizes human dendritic cells into Th2 cell-promoting effector dendritic cells. J. Immunol., 167, 3682-3686 https://doi.org/10.4049/jimmunol.167.7.3682
  4. Cumberbatch, M., Clelland, K., Dearman, R.J. and Kimber, I. (2005): Impact of cutaneous IL-10 on resident epidermal Langerhans' cells and the development of polarized immune responses. J. Immunol., 175, 43-50 https://doi.org/10.4049/jimmunol.175.1.43
  5. Friedmann, P.S. (2006): Contact sensitization and allergic contact dermatitis:Immunobiological mechanisms. Toxicol. Lett., 162, 49-54 https://doi.org/10.1016/j.toxlet.2005.10.008
  6. Goutet, M., Pepin, E., Langonne, I., Huguet, N. and Ban, M. (2005): Identification of contact and respiratory sensitizers using flow cytometry. Toxicol. Appl. Pharmacol., 205, 259-270 https://doi.org/10.1016/j.taap.2004.10.011
  7. Heo, Y., Parsons, P.J. and Lawrence, D.A. (1996): Lead differentially modifies cytokine production in vitro and in vivo. Toxicol. Appl. Pharmacol., 138, 149-157 https://doi.org/10.1006/taap.1996.0108
  8. Hilkens, C.M., Kalinski, P., de Boer, M. and Kapensberg, M.L. (1997): Human dendritic cells require exogenous interleukin- 12-inducing factors to direct the development of naive T-helper cells toward the Th1 phenotype. Blood, 90, 1920-1926
  9. Kepron, M.R., Chen, Y.W., Uhr, J.W. and Vitetta, E.S. (1989): IL-4 induced the specific rearrangement of gamma 1 genes on the expressed and unexpressed chromosomes of lipopolysaccharide-activated normal murine B cells. J. Immunol., 143, 334-339
  10. Kiekens, R.C.M., Thepen, T., Oosting, A.J., Bihari, I.C., van de Winkel, J.G.J., Bruijnzeel-Koomen, C.A.F.M. and Knol, E.F. (2001): Heterogeneity within tissue-specific macrophage and dendritic cell populations during cutaneous inflammation in atopic dermatitis. Br. J. Dermatol., 145, 957-965 https://doi.org/10.1046/j.1365-2133.2001.04508.x
  11. Kitagaki, H., Ono, N., Hayakawa, K., Kitazawa, T., Watanabe, K. and Shiohara, T. (1997): Repeated elicitation of contact hypersensitivity induces a shift in cutaneous cytokine milieu from a T helper cell type 1 to a T helper cell type 2 profile. J. Immunol., 159, 2484-2481
  12. Leung, D.Y.M., Tharp, M. and Boguiewicz, M. (1999): Atopic dermatitis in Fitzpatrick's Dermatology in General Medicine (I.M. Freedberg, A.Z. Eisen, K. Wolff, K.F. Austen, L.A. Goldsmith, S.I. Katz, T.B. Fitzpatrick Ed.). McGraw-Hill, New York, pp. 1464-1480
  13. Matsumoto, M., Ra, C., Kawamoto, K., Sato, H., Itakura, A., Sawada, J., Ushio, H., Suto, H., Mitsuishi, K., Hikasa, Y. and Matsuda, H. (1999): IgE hyperproduction through enhanced tyrosine phosphorylation of Janus kinase 3 in NC/Nga mice, a model for human atopic dermatitis. J. Immunol., 162, 1056-1063
  14. Mueller, D.L., Jenkins, M.K. and Schwarz, R.H. (1989): Clonal expansion versus functinal clonal inactivation: A costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Ann. Rev. Immunol., 7, 445-480 https://doi.org/10.1146/annurev.iy.07.040189.002305
  15. Ohmen, J.D., Hanifin, J.M., Nickoloff, B.J., Rea, T.H., Wyzykowski, R., Kim, J., Jullien, D., McHugh, T., Nassif, A.S., Chan, S.C. and Modlin, R.L. (1995): Overexpression of IL-10 in atopic dermatitis. J. Immunol., 154, 1956-1963
  16. Plitnick, L.M., Loveless, S.E., Ladics, G.S., Holsapple, M.P., Selgrade, M.J., Sailstad, D.M. and Smialowicz, R.J. (2002): Cytokine profiling for chemical sensitizers: Application of the ribonuclease protection assay and effect of dose. Toxicol. Appl. Pharmacol., 179, 145-154 https://doi.org/10.1006/taap.2002.9370
  17. Sikorski, E.E., Gerberick, G.F., Ryan, C.A., Miller, C.M. and Ridder, G.M. (1996): Phenotypic analysis of lymphocyte subpopulations in lymph nodes draining the ear following exposure to contact allergens and irritants. Fund. Appl. Toxicol., 34, 25-35 https://doi.org/10.1006/faat.1996.0172
  18. Snapper, C.M. and Paul, W.E. (1987): Interferon-${\gamma}$ and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science, 236, 944-947 https://doi.org/10.1126/science.3107127
  19. Tsunemi, Y., Saeki, H., Nakamura, K., Sekiya, T., Hirai, K., Kakinuma, T., Fujita, H., Asano, N., Tanida, Y., Wakugawa, M., Torii, H. and Tamaki, K. (2002): Interleukin- 13 gene polymorphism G4257A is associated with atopic dermatitis in Japanese patients. J. Dermatol. Sci., 30, 100-107 https://doi.org/10.1016/S0923-1811(02)00065-8
  20. US Dept. Health and Human Services (2003): Atopic dermatitis (A type of eczema). NIH publication No. 03-4272, Bethesda. USA
  21. Wiemann, C., Berthold, K., Heusener, A., Kruger, N., Seeberger, A. and Stropp, G. (2002): Joint positive control testing in guinea pig skin sensitization tests. Reg. Toxicol. Pharmacol., 35, 14-22 https://doi.org/10.1006/rtph.2001.1503
  22. 김영옥, 김광호, 박현지, 박영철, 박성욱, 허용 (2005): 마우스를 이용한 송화분 섭취의 면역원성과 안전성 탐색. 한국독성학회지, 21, 235-240
  23. 백도명, 박두용, 허용, 성주헌, 김호 (2002): 우리나라 환경오염으로 인한 건강영향의 특성과 그 규모 파악. 보건의료기술연구개발사업 보고서, 보건복지부
  24. 허용, 김광호 (2002): 백신 접종후 발생할 수 있는 전신적과민증 예측을 위한 아급성 실험동물 모형 개발과 관련 면역독성학적 지표치 평가. 한국독성학회지, 18, 205-213